scholarly journals Pediatric Emergency Department Responses to COVID-19: Transitioning From Surge Preparation to Regional Support

2020 ◽  
pp. 1-7
Author(s):  
Emily A. Hartford ◽  
Ashley Keilman ◽  
Hiromi Yoshida ◽  
Russell Migita ◽  
Todd Chang ◽  
...  
Keyword(s):  
United States ◽  
Emergency Department ◽  
Pediatric Patients ◽  
The United States ◽  
Pediatric Emergency ◽  
Pediatric Emergency Department ◽  
The Novel ◽  
Global Pandemic ◽  
The World ◽  
Novel Coronavirus

ABSTRACT In the midst of a global pandemic, hospitals around the world are working to meet the demand for patients ill with the 2019 coronavirus disease (COVID-19) caused by the novel coronavirus first identified in Wuhan, China. As the crisis unfolds, several countries have reported lower numbers as well as less morbidity and mortality for pediatric patients. Thus, pediatric centers find themselves pivoting from preparing for a patient surge to finding ways to support the regional response for adults. This study describes the response from 2 West Coast freestanding academic children’s hospitals that were among the first cities in the United States impacted during this pandemic.

scholarly journals International Travel is Not a Significant Risk of Exposure for Patients at a Midwestern United States Travel Clinic

2020 ◽  
Author(s):  
Pooja Patel ◽  
Hans House
Keyword(s):  
United States ◽  
Significant Risk ◽  
Retrospective Chart Review ◽  
The United States ◽  
International Travel ◽  
The Novel ◽  
The World ◽  
Novel Coronavirus ◽  
The Western Pacific ◽  
Travel Clinic

Abstract The Novel Coronavirus (SARS-CoV-2) was introduced into the United States via travel from Asia and Europe, although the extent of the spread of the disease was limited in the early days of the pandemic. Consequently, international travel may have played a role in the transmission of the disease into Iowa. This study seeks to determine how preferences for international travel changed as novel Coronavirus Disease (COVID-19) spread throughout the world and if any of these returning travelers developed COVID-19 as a result of their trips. This is a retrospective chart review of patients presenting to a travel clinic in Bettendorf, Iowa for pre-travel advice and vaccinations. From October 2019 to March 2020, four hundred twelve (n=412) patients presented to the clinic. Intended travel to the Western Pacific region (China, Japan, Korea, etc.) decreased dramatically during the study period. All 412 patients were followed in the electronic medical record for the period after their planned travel and only three (3) presented for COVID-19 testing. Two (2) tested positive, and both of these infections were linked to workplace exposures and not due to travel. News of the growing pandemic and travel warnings likely altered patients’ travel plans and decreased travel to the most affected regions of the world in the early months of the COVID-19 pandemic. Based on our study, travel was not a significant source of COVID-19 exposure for patients seen at this clinic.

scholarly journals Brewery Packaging in a Post-COVID Economy within the United States

Beverages ◽  
2021 ◽  
Vol 7 (1) ◽  
pp. 14
Author(s):  
Eric R. Pitts ◽  
Katherine Witrick
Keyword(s):  
United States ◽  
Supply Chain ◽  
Business Models ◽  
The United States ◽  
The Novel ◽  
Brewing Industry ◽  
Beer Industry ◽  
The World ◽  
Aluminum Cans ◽  
Novel Coronavirus

The 2020 pandemic caused by the novel coronavirus, SARS-CoV-2, also referred to as the COVID-19 [named for the disease caused by the virus] pandemic, shook the world to its core. Not only were populations hurt by the virus physically, the pandemic had deep repercussions economically as well. One of the industries severely impacted by the implications of the 2020 COVID-19 pandemic was the brewing industry, particularly that of the United States. The economic turmoil and uncertainty were felt by both macro and micro brewers alike. Draft beer sales virtually dried up overnight as state-imposed shutdowns closed bars, restaurants, and taprooms as a means to curb the spread of the virus. There were supply chain and logistical issues that arose during the pandemic due to not only closures within the brewing industry but supporting industries such as printers and shippers. In some cases, entire business models had to be turned completely on their head in an instant and business pivots had to be made. The year 2020 was wrought with challenges faced by the brewing industry. There was one saving grace however that kept many breweries afloat during the pandemic, and that was packaged beverage sales, especially those packages intended for off-site consumption. Set forth by trends of the pre-pandemic years aluminum cans and canning reigned supreme for the craft brewing market and allowed breweries to get product into the hands of consumers and ultimately allowed some breweries to stay open. Other options breweries had included the use of glass growlers or aluminum crowlers as a means to sell draft products to-go. The resourcefulness of many brewery owners was tested in 2020 and many rose to the challenge. This report aims to examine several of the challenges, pivots, and solutions packaging provided to the beer industry during the pandemic.

scholarly journals International Travel is Not a Significant Risk of Exposure for Patients at a Midwestern United States Travel Clinic

2020 ◽  
Author(s):  
Hans House ◽  
Pooja Patel
Keyword(s):  
United States ◽  
Significant Risk ◽  
The United States ◽  
International Travel ◽  
The Novel ◽  
The World ◽  
Risk Of Exposure ◽  
Novel Coronavirus ◽  
The Western Pacific

Abstract The Novel Coronavirus (SARS-CoV-2) was introduced into the United States due to travel from Asia and Europe, although the extent of the spread of the disease was limited in the early days of the Pandemic. International travel may have played a role in the transmission of the disease into Iowa. Persons planning international travel likely modified their travel plans as a result of the viral outbreak. This study, documenting the travel destinations of patients from a clinic in Bettendorf, Iowa, seeks to determine how preferences for international travel changed as Coronavirus Disease (COVID-19) spread throughout the world and if any of these patients developed COVID-19 as a result of their travel. From October 2019 to March 2020, four hundred twelve (n=412) patients presented for pre-travel advice. Intended travel to the Western Pacific region (China, Japan, Korea, etc.) decreased dramatically during the study period. Of the 412 patients, only three (3) presented for COVID-19 testing during the follow-up period. Two (2) tested positive, and both of these infections were linked to workplace exposures and not due to travel. News of the growing pandemic and travel warnings likely altered patient’s travel plans and fewer intended travel to the most affected regions of the world in the early months of the COVID-19 pandemic. Travel was not a significant source of COVID-19 exposure for patients seen at this clinic.

scholarly journals Low-Value Diagnostic Imaging Use in the Pediatric Emergency Department in the United States and Canada

2019 ◽  
Vol 173 (8) ◽  
pp. e191439 ◽  
Author(s):  
Eyal Cohen ◽  
Jonathan Rodean ◽  
Christina Diong ◽  
Matt Hall ◽  
Stephen B. Freedman ◽  
...  
Keyword(s):  
United States ◽  
Emergency Department ◽  
Diagnostic Imaging ◽  
The United States ◽  
Pediatric Emergency ◽  
Pediatric Emergency Department

scholarly journals COVID-19 Result Follow-up Process in the Pediatric Emergency Department Setting

2020 ◽  
pp. 1-11
Author(s):  
Shaina Newman ◽  
Joelle Simpson ◽  
Ashley Perritt ◽  
Sephora Morrison ◽  
Deena Berkowitz ◽  
...  
Keyword(s):  
Emergency Department ◽  
Pediatric Emergency ◽  
Pediatric Emergency Department ◽  
The Novel ◽  
Antibody Testing ◽  
National Hospital ◽  
Good Patient ◽  
Emergency Department Setting ◽  
Novel Coronavirus

Abstract The novel coronavirus (COVID-19) pandemic upended the world. As emergency departments and hospitals across the nation and world braced themselves for the surge of this new disease, the Emergency Department (ED) at Children’s National Hospital (CNH) quickly created a process to address surges in patient visits and follow-ups for coronavirus testing. Within two weeks of the first reported pediatric patient diagnosed with COVID-19 in the DC metropolitan area, CNH ED implemented a new comprehensive follow-up process. This article describes the novel process which ensured timely notification of testing results, enabled patients to speak remotely with ED providers, increased patient and staff safety by reducing unnecessary exposures and suggested a good patient experience. With over 1900 patients discharged pending their COVID results, the program is successful. We anticipate expansion into antibody testing and notification as the pandemic progresses.

scholarly journals International travel is not a significant risk of exposure for patients at a Midwestern United States travel clinic

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Pooja Patel ◽  
Hans R. House
Keyword(s):  
United States ◽  
Significant Risk ◽  
Retrospective Chart Review ◽  
The United States ◽  
International Travel ◽  
The Novel ◽  
The World ◽  
Novel Coronavirus ◽  
The Western Pacific ◽  
Travel Clinic

AbstractThe Novel Coronavirus (SARS-CoV-2) was introduced into the United States via travel from Asia and Europe, although the extent of the spread of the disease was limited in the early days of the pandemic. Consequently, international travel may have played a role in the transmission of the disease into Iowa. This study seeks to determine how preferences for international travel changed as novel Coronavirus Disease (COVID-19) spread throughout the world and if any of these returning travelers developed COVID-19 as a result of their trips. This is a retrospective chart review of patients presenting to a travel clinic in Bettendorf, Iowa for pre-travel advice and vaccinations. From October 2019 to March 2020, four hundred twelve (n = 412) patients presented to the clinic. Intended travel to the Western Pacific region (China, Japan, Korea, etc.) decreased dramatically during the study period. All 412 patients were followed in the electronic medical record for the period after their planned travel and only three (3) presented for COVID-19 testing. Two (2) tested positive, and both of these infections were linked to workplace exposures and not due to travel. News of the growing pandemic and travel warnings likely altered patients’ travel plans and decreased travel to the most affected regions of the world in the early months of the COVID-19 pandemic. Based on our study, travel was not a significant source of COVID-19 exposure for patients seen at this clinic.

scholarly journals Pediatric Emergency Department Utilization and Reliance by Insurance Coverage in the United States

2017 ◽  
Vol 24 (12) ◽  
pp. 1483-1490 ◽  
Author(s):  
Lauren E. Schlichting ◽  
Michelle L. Rogers ◽  
Annie Gjelsvik ◽  
James G. Linakis ◽  
Patrick M. Vivier
Keyword(s):  
United States ◽  
Emergency Department ◽  
Insurance Coverage ◽  
The United States ◽  
Pediatric Emergency ◽  
Emergency Department Utilization ◽  
Pediatric Emergency Department

scholarly journals International Travel is Not a Significant Risk of Exposure for Patients at a Midwestern United States Travel Clinic

2020 ◽  
Author(s):  
Pooja Patel ◽  
Hans House
Keyword(s):  
United States ◽  
Significant Risk ◽  
Retrospective Chart Review ◽  
The United States ◽  
International Travel ◽  
The Novel ◽  
The World ◽  
Novel Coronavirus ◽  
The Western Pacific ◽  
Travel Clinic

Abstract The Novel Coronavirus (SARS-CoV-2) was introduced into the United States via travel from Asia and Europe, although the extent of the spread of the disease was limited in the early days of the pandemic. Consequently, international travel may have played a role in the transmission of the disease into Iowa. This study seeks to determine how preferences for international travel changed as novel Coronavirus Disease (COVID-19) spread throughout the world and if any of these returning travelers developed COVID-19 as a result of their trips. This is a retrospective chart review of patients presenting to a travel clinic in Bettendorf, Iowa for pre-travel advice and vaccinations. From October 2019 to March 2020, four hundred twelve (n=412) patients presented to the clinic. Intended travel to the Western Pacific region (China, Japan, Korea, etc.) decreased dramatically during the study period. All 412 patients were followed in the electronic medical record for the period after their planned travel and only three (3) presented for COVID-19 testing. Two (2) tested positive, and both of these infections were linked to workplace exposures and not due to travel. News of the growing pandemic and travel warnings likely altered patients’ travel plans and decreased travel to the most affected regions of the world in the early months of the COVID-19 pandemic. Based on our study, travel was not a significant source of COVID-19 exposure for patients seen at this clinic.

Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19

2020 ◽  
Vol 20 ◽  
Author(s):  
Ekta Shirbhate ◽  
Preeti Patel ◽  
Vijay K Patel ◽  
Ravichandran Veerasamy ◽  
Prabodh C Sharma ◽  
...  
Keyword(s):  
Therapeutic Option ◽  
Antiviral Treatment ◽  
The Novel ◽  
Clinical Experiences ◽  
Synthetic Compounds ◽  
Synthetic Drugs ◽  
Global Pandemic ◽  
The World ◽  
Novel Coronavirus

: The novel coronavirus disease-19 (COVID-19), a global pandemic that emerged from Wuhan, China has today travelled all around the world, so far 216 countries or territories with 21,732,472 people infected and 770,866 deaths globally (as per WHO COVID-19 update dated August 18, 2020). Continuous efforts are being made to repurpose the existing drugs and develop vaccines for combating this infection. Despite, to date, no certified antiviral treatment or vaccine prevails. Although, few candidates have displayed their efficacy in in vitro studies and are being repurposed for COVID-19 treatment. This article summarizes synthetic and semi-synthetic compounds displaying potent activity in their clinical experiences or studies against COVID-19 and also focuses on mode of action of drugs being repositioned against COVID-19.

Sign in / Sign up

Export Citation Format

Share Document